For a nation battered by opioids and haunted by the failures of big pharma, 7-hydroxymitragynine (7-OH) might seem like a molecule worth studying. Instead, regulators are preparing to bury it.
The FDA's recent recommendation to schedule 7-OH , a naturally occurring kratom alkaloid found both in the plant and metabolically produced in the body is yet another example of policy outpacing science. And this time, the cost might be the loss of a promising, safer opioid-alternative before it ever gets the chance to evolve.
A Safer Opioid-Like Tool the FDA Would Rather You Not Understand
7-OH isn’t synthetic. It doesn’t come from a clandestine lab. It’s part of a centuries-old botanical Mitragyna speciosa , better known as kratom used traditionally in Southeast Asia for energy, endurance,